Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Apr 28;11(2):67.
doi: 10.3390/diseases11020067.

Mucopolysaccharidosis Type I Presenting with Persistent Neonatal Respiratory Distress: A Case Report

Ali Alsuheel Asseri  1 , Ahmad Alzoani  2 , Abdulwahab M Almazkary  3 , Nisreen Abdulaziz  2 , Mufareh H Almazkary  2 , Samy Ailan Alahmari  2 , Arul J Duraisamy  4 , Shruti Sureshkumar  4
Affiliations
Case Reports

Mucopolysaccharidosis Type I Presenting with Persistent Neonatal Respiratory Distress: A Case Report

Ali Alsuheel Asseri et al. Diseases. .

Abstract

Mucopolysaccharidosis type I (MPS I) is a rare inherited autosomal recessive lysosomal storage disorder. Despite several reports on MPS I-related neonatal interstitial lung disease, it is still considered to be an under-recognized disease manifestation. Thus, further study of MPS I is required to improve specific therapies and management strategies. The current report describes a late preterm baby (36 weeks gestational age) with neonatal onset of interstitial lung disease eventually diagnosed as MPS I. The neonate required prolonged respiratory support and oxygen supplementation that further escalated the likely diagnosis of inherited disorders of pulmonary surfactant dysfunction. Whole-exome sequencing confirmed the diagnosis of MPS I, following the observation of low levels of the enzyme α-L-iduronidase. The results highlight the necessity of considering MPS I-related pulmonary involvement in newborns with persistent respiratory insufficiency.

Keywords: MPS I; neonatal respiratory distress; pulmonary surfactant dysfunction; α-L-iduronidase.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chest radiography (CXR) (2 h after birth) revealed diffuse bilateral lung ground-glass opacities with air bronchograms (arrows); L = left.
Figure 2
Figure 2
Chest-contrasted computed tomography (CT) findings of the patient: (A) Coronal CT chest image showed aeration of the large airways, with ground-glass material filling the distal airspaces and interlobular septal thickening (arrows). (B,C) Axial CT chest images showed extensive ground-glass opacification/consolidation of both lungs (arrows).
Figure 3
Figure 3
Chest radiography (CXR) (at 2 months) and the patient’s facial features at the age of 2 months: (A) CXR (at 2 months) revealed a persistent bilateral ground-glass appearance (arrows). (B) The patient at the age of 2 months showed mild dysmorphic facial features, including mild coarse facial features, a short and flat nose with wide nostrils, broad eyebrows with mild synophrys, and facial hypertrichosis. L, left.
Figure 4
Figure 4
Timeline from the first presentation to the age of 15 months (12 months after the initiation of enzyme replacement therapy).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Węgrzyn G., Pierzynowska K., Pavone L.M. Editorial: Molecular Aspects of Mucopolysaccharidoses. Front. Mol. Biosci. 2022;9:874267. doi: 10.3389/fmolb.2022.874267. - DOI - PMC - PubMed
    1. Voskoboeva E.Y., Bookina T.M., Semyachkina A.N., Mikhaylova S.V., Vashakmadze N.D., Baydakova G.V., Kutsev S.I. Mucopoly-saccharidosis Type I in the Russian Federation and Other Republics of the Former Soviet Union: Molecular Genetic Analysis and Epidemiology. Front. Mol. Biosci. 2022;8:783644. doi: 10.3389/fmolb.2021.783644. - DOI - PMC - PubMed
    1. Campos D., Monaga M. Mucopolysaccharidosis type I: Current knowledge on its pathophysiological mechanisms. Metab. Brain Dis. 2012;27:121–129. doi: 10.1007/s11011-012-9302-1. - DOI - PubMed
    1. Clarke L.A., Giugliani R., Guffon N., Jones S.A., Keenan H.A., Munoz-Rojas M.V., Okuyama T., Viskochil D., Whitley C.B., Wijburg F.A., et al. Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry. Clin. Genet. 2019;96:281–289. doi: 10.1111/cge.13583. - DOI - PMC - PubMed
    1. Hampe C., Eisengart J., Lund T., Orchard P., Swietlicka M., Wesley J., McIvor R. Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology. Cells. 2020;9:1838. doi: 10.3390/cells9081838. - DOI - PMC - PubMed

Publication types

LinkOut - more resources